Hereditary gastrointestinal syndromes and genetic disorders play a critical role in cancer predisposition, inflammatory conditions, and congenital GI abnormalities. Advances in genetic testing, next-generation sequencing, and molecular diagnostics have transformed early detection and risk assessment. Identifying pathogenic variants enables targeted surveillance, preventive strategies, and personalized treatment plans. Genetic counseling and family-based screening are essential components of comprehensive care. Research continues to uncover novel genetic pathways influencing disease susceptibility and progression. This topic focuses on integrating genetics into clinical gastroenterology, highlighting advances in precision medicine, ethical considerations, and the role of genomics in improving long-term outcomes.